Atara Biotherapeutics (AT20.STU) Q1 2026 Earnings

16MarConfirmed
Q1 2026
-0.22
-0.2
-0.17
-0.15

Details

Expected EPS
-0.152989025
Actual EPS
-0.2174375
Surprise EPS
-0.06
Surprise Percent
+42.13%

Description

Atara Biotherapeutics (AT20.STU) has reported earnings of -0.2174375 per share for Q1 2026.

0 Comments

Share your thoughts